Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZONE: ZT-01 for Nocturnal Hypoglycemia in Type 1 Diabetes
NCT05762107Phase 2Recruiting
- Sponsor
- Zucara Therapeutics Inc.
- Start
- Jul 2023
- Primary completion
- Dec 2026
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ZT-01 in type 1 diabetes mellitus (T1D), sponsored by Zucara Therapeutics Inc.. Started Jul 2023; status: recruiting.
02
Drugs
ZT-01
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05762107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05762107.